Agoracom Blog Home

Archive for the ‘Predictmedix Inc.’ Category

Predictmedix Inc. $PMED.ca $PMEDF Secures Strategic Financing to Catalyze Operations

Posted by AGORACOM-AB at 10:37 AM on Friday, March 5th, 2021

TORONTO, March 05, 2021 — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities. The Company is proud to announce that it has closed a non-brokered private placement for gross proceeds of $1,090,085 in a strategic financing round to catalyze the Company’s operations as it scales its business.

A total of 3,114,529 units were issued at a price of $0.35 each. Each unit is comprised of one common share of the Company and one warrant, with each warrant exercisable into a common share at an exercise price of $0.50 per share for a period of two years.

The shares and warrants comprising the units issued pursuant to the offering are subject to a statutory four month and one day hold period from the date of issue in accordance with applicable Canadian securities laws.

Predictmedix recently entered the live event space with the deployment of our Safe Entry Solutions unit at the Superbowl after-party held at Tampa Bay, Florida.

The event was incredibly successful, as our product deployments were able to immediately detect an individual that exhibited symptoms for COVID-19. The story received national press coverage and made the front page of Tampa Bay Times, reaching over 1.6 million weekly readers.

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/756658-predictmedix-inc-secures-strategic-financing-to-catalyze-operations/messages/2306673#message

VIDEO – PredictMedix $PMED.ca $PMEDF Screening Devices Use Artificial Intelligence To Detect Viruses & Impairment At Super Bowl Events. Prepares Massive Rollout With Tier-1 Partners

Posted by AGORACOM-JC at 6:35 PM on Monday, February 15th, 2021
Predictmedix Inc. (CSE: PMED | OTCQB: PMEDF) | LinkedIn

Predictmedix $PMED $PMEDF Is What Happens When You Combine Artificial Intelligence With Contactless Screening To Detect Viruses, Impairment And Even Mental Illness.

Predictmedix is an Artificial Intelligence Company that has developed fast, non-invasive, contactless screening devices that detect infectious diseases, impairment and even mental illness at any location where mass amounts of people gather. Specifically, they determine the probability of a person being infected so safety protocols can be initiated.

$PMED screeners are fully automated and intelligent, so they don’t need personnel to operate them.   

THE PROBLEM – TEMPERATURE GUNS DON’T HELP DETECT COVID-19 

3RD PARTY VALIDATION

More than just lip service, Predictmedix recently partnered with Wellness for Humanity to deploy Safe Entry Stations at the Big Game festivities in Tampa, Florida, ahead of the SuperBowl.

Moreover, they have partnered with some incredible global giants like Tech Mahindra, a multi-billion dollar company with Fortune 500 clients, to be the first to roll out the technology. How big is Tech Mahindra?

  • Named in the Top 15 Global IT Companies by Forbes
  • Highest Ranked Non-US company in Forbes Global Digital 100 List (2018)
  • Named in the Forbes Fab 50 Companies in Asia (2018)

Tech Mahindra will resell $PMED scanners to their entire client base after a successful pilot.

$PMED has even further 3rd party validation and exciting applications for their technology, so make sure to watch this great interview with COO Dr. Rahual Kushwah to learn all about the Company and where it is going.

Predictmedix Inc. $PMED.ca $PMEDF Announces Results of its Annual and Special Meeting of Shareholders

Posted by AGORACOM-AB at 5:16 PM on Friday, January 29th, 2021
  • Sheldon Kales, Rahul Kushwah, Tomas Sipos and Ajit Kumar re-elected as directors of the company.

TORONTO, ON / ACCESSWIRE / January 29, 2021 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the”Company“) is pleased to announce the results of its Annual General and Special Meeting of Shareholders held on January 28, 2021 at 10:00 a.m. (the “Meeting“). The requisite approval of shareholders for the following items, all as more particularly described in the information circular of the Company dated December 21, 2020 (the “Circular“), was received at the Meeting:

1. setting the number of directors of the Company at four;

2. the re-election of Sheldon Kales, Rahul Kushwah, Tomas Sipos and Ajit Kumar as directors of the Company for the ensuing year;

3. the re-appointment of Harbourside CPA LLP (previously Buckley Dodds LLP) as the Company’s auditors; and

4. the authorization of the Company to make an application to the Supreme Court of British Columbia pursuant to Section 229 of Business Corporations Act (British Columbia) (“Section 229 Application“).

The only omissions, defects, errors or irregularities the Company sought to rectify through the Section 229 Application was the Company’s failure to hold an annual general meeting during the 2019 calendar year and distribute interim and annual financial statements. There were no other undisclosed omissions, defects, errors or irregularities that Predictmedix needed to cure.

Read more: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/754231-predictmedix-announces-results-of-its-annual-and-special-meeting-of-shareholders/messages/2301062#message

Predictmedix Inc. $PMED.ca $PMEDF Provides Corporate Update

Posted by AGORACOM-JC at 7:44 AM on Monday, January 25th, 2021
Predictmedix Inc. (CSE: PMED | OTCQB: PMEDF) | LinkedIn
  • Initiatives and developments outlined below are in line with our larger goal of being the market leader in workplace health and safety by offering artificial intelligence powered technologies which address the major issues encountered in workplaces
  • Successfully deployed its technologies for beta testing purposes with major partners in North America and Asia, including India Oil (a fortune 500 corporation), MGM Hospital COVID-19 ward (one of the largest COVID-19 hospitals in Mumbai, India) and Flow Water.
  • Deployment at MGM Hospital is strategic to ensure our AI algorithms adapt to symptom associated changes brought on by new COVID-19 variants.
  • In other words, this allows our AI algorithm to adapt to the mutating virus.
  • Once learned, the technology is deployed immediately and is simultaneously functional across all present deployments.

TORONTO, Jan. 25, 2021 — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF)(“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities. This update will outline current progress, advancements of the Company and shed light on other corporate developments as the past few months have been about laying the groundwork for our long-term success. The initiatives and developments outlined below are in line with our larger goal of being the market leader in workplace health and safety by offering artificial intelligence powered technologies which address the major issues encountered in workplaces. 

Public showcase of our technology in New York City

Predictmedix and Juiceworks’ Safe Entry Station will be showcased in a Live event on Jan 26, 2021 in New York City by Wellness4Humanity.

Wellness4Humanity’s New York City (NYC) flagship location opens at 225 West 34th Street near Pennsylvania Station in the heart of Herald Square in the two-story high-impact space formerly occupied by Lane Bryant. The flagship location will be showcasing a Safe Entry Station powered by Predictmedix’s proprietary infectious disease symptom screening technology.

– Here is a link to a demo of our technology: https://www.youtube.com/watch?v=phziV7OBkjY

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/753837-predictmedix-inc-provides-corporate-update/messages/2300006#message